Boston Scientific won FDA approval to introduce its Resonate line of implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D). The same products were approved in Europe via a CE Mark earlier this year.
Some of the notable features of the Resonate devices include multi-electrode pacing and integrati (Read more...)